Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

JDOC vs. ETHSX: which is better?

Bottom line

JDOC vs ETHSX: the short answer

JDOC (JPMorgan Healthcare Leaders ETF) and ETHSX (Eaton Vance Worldwide Health Sciences Fund) share a meaningful slice of their top holdings — about 63% by weight.

JDOC is cheaper at 0.65% vs 1.18% — a difference of $53 a year per $10,000 invested.

Over one year, JDOC returned +14.9% vs −1.9% for ETHSX (reporting dates differ).

ETHSX has a front-end sales load of up to 5.25%; the other does not.

Updated Nov 19, 2026

JDOC vs ETHSX side by side

JDOCETHSX
TypeETFMutual fund
Fund familyJ.P. MorganMorgan Stanley
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.65%1.18%
Annual cost per $10k$65$118
10-yr cost on $10k (prospectus)$810$1,911
Max front loadNone5.25%
12b-1 fee—0.25%
1-yr return+14.9%−1.9%
5-yr return (annualized)—+5.3%
10-yr return (annualized)—+6.4%
Best quarter+11.3%+14.2%
Worst quarter−11.9%−12.1%
Net assets (fund)$9.1M$757.9M
Number of holdings6142
Portfolio turnover92%3%
Returns as ofDec 31, 2025Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearJDOCETHSXDifference
2024−0.6%+3.5%−4.2%

Source: Fund prospectus bar charts

Holdings overlap

14 of JDOC's top 25 holdings also appear in ETHSX's top 25.

Shared top holdings
HoldingJDOCETHSX
AbbVie, Inc.7.85%6.46%
Eli Lilly & Co.7.76%12.47%
UnitedHealth Group, Inc.5.85%5.49%
Merck & Co., Inc.4.82%5.08%
Johnson & Johnson4.82%6.45%
AstraZeneca plc3.76%6.24%
Thermo Fisher Scientific, Inc.3.73%2.79%
Bristol-Myers Squibb Co.3.57%4.25%
Abbott Laboratories3.11%1.65%
Roche Holding AG2.82%5.44%
Novo Nordisk A/S2.61%1.71%
Stryker Corp.2.23%2.21%
Intuitive Surgical, Inc.1.93%2.72%
Novartis AG1.60%1.65%

Source: SEC Form N-PORT

JDOC top 10

  1. AbbVie, Inc. — 7.85%
  2. Eli Lilly & Co. — 7.76%
  3. UnitedHealth Group, Inc. — 5.85%
  4. Merck & Co., Inc. — 4.82%
  5. Johnson & Johnson — 4.82%
  6. AstraZeneca plc — 3.76%
  7. Thermo Fisher Scientific, Inc. — 3.73%
  8. Bristol-Myers Squibb Co. — 3.57%
  9. Abbott Laboratories — 3.11%
  10. CVS Health Corp. — 2.83%

ETHSX top 10

  1. Eli Lilly & Co — 12.47%
  2. AbbVie Inc — 6.46%
  3. Johnson & Johnson — 6.45%
  4. AstraZeneca PLC — 6.24%
  5. UnitedHealth Group Inc — 5.49%
  6. Roche Holding AG — 5.44%
  7. Merck & Co Inc — 5.08%
  8. Bristol-Myers Squibb Co — 4.25%
  9. Vertex Pharmaceuticals Inc — 3.38%
  10. Gilead Sciences Inc — 3.34%

FAQ

What is the difference between JDOC and ETHSX?
JDOC (JPMorgan Healthcare Leaders ETF) and ETHSX (Eaton Vance Worldwide Health Sciences Fund) share a meaningful slice of their top holdings — about 63% by weight. JDOC is cheaper at 0.65% vs 1.18% — a difference of $53 a year per $10,000 invested.
Which is cheaper, JDOC or ETHSX?
JDOC has the lower expense ratio (0.65%).
Should I own both JDOC and ETHSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.